Replies to post #81698 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Six month trials are not unknown. If the current data says SOC fails within six months and there is a marked improvement over SOC at that time the trial can be planned for six months or when certain events occur.

Then the political pressure will be on the FDA to approve it in record time.

Now tell me you would turn down a 2:1 or 3:1 offer.

$100-$150 per share on your $4 investment and you still get to participate in future growth?